Tricyclic compounds useful as inhibitors of kinases
Details for Australian Patent Application No. 2006316322 (hide)
International Classifications
Event Publications
29 May 2008 PCT application entered the National Phase
PCT publication WO2007/061764 Priority application(s): WO2007/061764
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Frosst Canada Ltd.; Merck Sharp & Dohme Corp. Amendments
25 August 2011 Application Accepted
Published as AU-B-2006316322
22 December 2011 Standard Patent Sealed
4 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Canada Inc.; Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser